These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8871601)

  • 41. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
    J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autosomal loci associated with a sex-related difference in the development of autoimmune phenotypes in a lupus model.
    Misu N; Zhang M; Mori S; Miyazaki T; Furukawa H; Sasaki T; Nose M; Ono M
    Eur J Immunol; 2007 Oct; 37(10):2787-96. PubMed ID: 17823981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells.
    Koh DR; Ho A; Rahemtulla A; Fung-Leung WP; Griesser H; Mak TW
    Eur J Immunol; 1995 Sep; 25(9):2558-62. PubMed ID: 7589126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Host modifier genes affect mouse autoimmunity induced by the lpr gene.
    Wang Y; Nose M; Kamoto T; Nishimura M; Hiai H
    Am J Pathol; 1997 Dec; 151(6):1791-8. PubMed ID: 9403730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen in autoimmunity: expression of estrogen receptors in thymic and autoimmune T cells.
    Törnwall J; Carey AB; Fox RI; Fox HS
    J Gend Specif Med; 1999; 2(5):33-40. PubMed ID: 11252833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
    Jimenez-Caliani AJ; Jimenez-Jorge S; Molinero P; Rubio A; Guerrero JM; Osuna C
    J Pineal Res; 2008 Sep; 45(2):204-11. PubMed ID: 18507713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of RANTES in the development of autoimmune tissue injuries in MRL-Fas lpr mice.
    Tsukahara T; Makino Y; Fujii T; Ogawa M; Saisho H; Hamano Y; Ueda S; Akikusa B; Danoff TM
    Clin Immunol; 2002 Apr; 103(1):89-97. PubMed ID: 11987989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MRL/lpr and MRL+/+ macrophage DNA synthesis in the absence and the presence of colony-stimulating factor-1 and granulocyte-macrophage colony-stimulating factor.
    Hamilton JA; Chan J; Byrne RJ; Bischof RJ; Jaworowski A; Kanagasundaram V
    J Immunol; 1998 Dec; 161(12):6802-11. PubMed ID: 9862711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on the role of the lpr gene in the development of immunological abnormalities and lupus nephritis. Analyses in F2 mice.
    Fujiwara M; Kariyone A; Shiraki M
    Clin Exp Immunol; 1985 Jan; 59(1):161-8. PubMed ID: 3918816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of inducible costimulator in the development of lupus in MRL/lpr mice.
    Tada Y; Koarada S; Tomiyoshi Y; Morito F; Mitamura M; Haruta Y; Ohta A; Nagasawa K
    Clin Immunol; 2006 Aug; 120(2):179-88. PubMed ID: 16616645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
    Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in hypothalamic-pituitary-adrenal function correlated with the onset of murine SLE in MRL +/+ and lpr/lpr mice.
    Shanks N; Moore PM; Perks P; Lightman SL
    Brain Behav Immun; 1999 Dec; 13(4):348-60. PubMed ID: 10600221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
    Fan JL; Himeno K; Tsuru S; Nomoto K
    Clin Exp Immunol; 1987 Oct; 70(1):94-101. PubMed ID: 3500817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody.
    Jabs DA; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2718-22. PubMed ID: 1680111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of combining ACE inhibitor and statin in lupus-prone mice.
    Shimazu H; Kinoshita K; Hino S; Yano T; Kishimoto K; Nagare Y; Nozaki Y; Sugiyama M; Ikoma S; Funauchi M
    Clin Immunol; 2010 Aug; 136(2):188-96. PubMed ID: 20403731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The tissue specific elevation in synthesis of the 90 kDa heat shock protein precedes the onset of disease in lupus prone MRL/lpr mice.
    Faulds GB; Isenberg DA; Latchman DS
    J Rheumatol; 1994 Feb; 21(2):234-8. PubMed ID: 8182630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
    Miyawaki S; Nakamura Y; Takeshita T; Yoshida H; Shibata Y; Mitsuoka S
    Lab Anim Sci; 1988 Jun; 38(3):266-72. PubMed ID: 2970562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies of lymphoproliferation in MRL-lpr/lpr mice.
    Smathers PA; Santoro TJ; Chused TM; Reeves JP; Steinberg AD
    J Immunol; 1984 Oct; 133(4):1955-61. PubMed ID: 6332142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Splenic norepinephrine is decreased in MRL-lpr/lpr mice.
    Breneman SM; Moynihan JA; Grota LJ; Felten DL; Felten SY
    Brain Behav Immun; 1993 Jun; 7(2):135-43. PubMed ID: 8347895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.